[go: up one dir, main page]

TNSN06299A1 - Oral matrix formulations comprising licarbazepine - Google Patents

Oral matrix formulations comprising licarbazepine

Info

Publication number
TNSN06299A1
TNSN06299A1 TNP2006000299A TNSN06299A TNSN06299A1 TN SN06299 A1 TNSN06299 A1 TN SN06299A1 TN P2006000299 A TNP2006000299 A TN P2006000299A TN SN06299 A TNSN06299 A TN SN06299A TN SN06299 A1 TNSN06299 A1 TN SN06299A1
Authority
TN
Tunisia
Prior art keywords
licarbazepine
matrix formulations
oral matrix
oral
formulations
Prior art date
Application number
TNP2006000299A
Other languages
French (fr)
Inventor
Marie-Christine Wolf
Oskar Kalb
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2005/002988 external-priority patent/WO2005092294A1/en
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of TNSN06299A1 publication Critical patent/TNSN06299A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)

Abstract

THE INVENTION RELATES TO PHARMACEUTICAL COMPOSITIONS COMPRISING 10,11-DIHYDRO-10-HYDROXY-5H-DIBENZ,[B,F]AZEPINE-5-CARBOXAMIDE (ALSO REFERRED TO AS "LICARBAZEPINE") AS DRUG SUBSTANCE.
TNP2006000299A 2004-03-22 2006-09-21 Oral matrix formulations comprising licarbazepine TNSN06299A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0406379A GB0406379D0 (en) 2004-03-22 2004-03-22 Organic compounds
PCT/EP2005/002988 WO2005092294A1 (en) 2004-03-22 2005-03-21 Oral matrix formulations comprising licarbazepine

Publications (1)

Publication Number Publication Date
TNSN06299A1 true TNSN06299A1 (en) 2007-12-03

Family

ID=32118143

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2006000299A TNSN06299A1 (en) 2004-03-22 2006-09-21 Oral matrix formulations comprising licarbazepine

Country Status (3)

Country Link
CN (1) CN1933819A (en)
GB (1) GB0406379D0 (en)
TN (1) TNSN06299A1 (en)

Also Published As

Publication number Publication date
GB0406379D0 (en) 2004-04-21
CN1933819A (en) 2007-03-21

Similar Documents

Publication Publication Date Title
CY1111470T1 (en) NEW PHARMACEUTICAL COMPOSITIONS CONTAINING FLYVERSERIN POLYMORPH A
BR0015188A (en) Pharmaceutical compositions
IL173571A0 (en) Injectable, oral, or topical sustained release pharmaceutical formulations
PL370292A1 (en) Formulations for oral administration of active compounds
ZA200608029B (en) Nitrogenous fused-ring derivatives, medicinal compositions containing the derivatives, and use thereof as drugs
IL173195A0 (en) Cyclovinylazoline derivatives, their preparation and pharmaceutical compositions containing them
AU2003246978A1 (en) Pharmaceutical compositions comprising cyclosporin for oral administration
AU2002309038A1 (en) Compositions for transmucosal administration containing coenzyme Q as the active ingredient
AU2003230189A1 (en) Oral controlled release pharmaceutical composition containing metaxalone as active agent
AP2005003375A0 (en) Antibacterial indolone oxazolidinones, intermediates for their preparation and pharmaceutical compositions containing them.
NO20064808L (en) Oral matrix formulations with licarbazepine
ATE286894T1 (en) 2H-1-BENZOPYRAN DERIVATIVES, PROCESSES FOR THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITIONS
WO2006056696A3 (en) 2-alcoxy-3,4,5-trihydroxy-alkylamides, preparation thereof, compositions containing them and use thereof
WO2004098577A3 (en) Dosage form containing (s)-pantoprazole as active ingredient
MX260260B (en) Semi-solid formulations for the oral administration of taxoids.
ECSP066872A (en) DISINTEGRANT TABLETS UNDERSTANDING LICARBAZEPINA
TW200503783A (en) Oral pharmaceutical preparation for proton pump antagonists
UA87152C2 (en) Solid pharmaceutical composition containing mirtazapine and method for preparation thereof
TNSN06299A1 (en) Oral matrix formulations comprising licarbazepine
GB0327390D0 (en) Pharmaceutical formulations
AU2003202550A1 (en) Pharmaceutical formulations with modified release
TNSN06298A1 (en) Disintegrating tablets comprising licarbazepine
ZA200501010B (en) BenzoÄBÜchromeno-naphthyridin-7-one and pyranoÄ2'3':7,8ÜquinoÄ2,3-BÜquinoxalin-7-one compounds, process for their preparation and pharmaceutical compositions containing them.
WO2001095890A3 (en) Oral pharmaceutical compositions containing terbinafine
TW200610526A (en) Novel hydrophilic analogs of 4,8-dihydrobenzodithiophene-4,8-diones as anticancer agents